Employee Spotlight

When Wang Donghua was tapped to hand-deliver personal protective equipment (PPE) and other supplies to healthcare facilities at the outset of the outbreak in Wuhan, he didn’t think twice. His wife happened to be one of those nurses on the front lines.

Imagine being a researcher who is staring down not only a highly infectious virus, but one that’s caused the first global pandemic in more than 100 years. Meet Johnson & Johnson’s Hanneke Schuitemaker, Ph.D.

When Melissa Surdez received an urgent call from her physician sister who was battling the pandemic on the front lines in New Jersey and facing a mask shortage, she promised to help—and tapped Johnson & Johnson’s thousands of employees to join her cause.

Johnson & Johnson has an expansive archive of existing drug compounds—and two researchers are leading the charge in combing through this molecular storehouse in pursuit of a possible breakthrough.

Roland Zahn, Ph.D., a Janssen scientist and expert in viral vaccines, was at the front lines of research during the Ebola outbreak. Today he and his team are working at record speed to help deliver a potential vaccine for the novel coronavirus.

In the 1930s the company commissioned a series of colorful panels to pay homage to men and women who worked at Johnson & Johnson. For Employee Appreciation Day, we tell the story behind the art.

Not all companies have a Chief Historian. Then again, not all companies have such a long, rich heritage of innovation. Margaret Gurowitz explains the highlights—and delights—of her unique job.

A visit back to her Kentucky roots with Save the Children brought Joy Marini full circle—and underscored the importance of the work she does with Johnson & Johnson to help children around the globe.

Frederick Shelton has spent 21 years engineering cutting-edge innovations to help propel medicine forward. On what would have been Thomas Edison’s 172nd birthday, this latter-day great American inventor shares the life-changing medical devices he’s most proud of designing.

In the lead-up to the recent International AIDS Society Conference on HIV Science in the Netherlands, we sat down with Hanneke Schuitemaker, who’s hard at work on the holy grail of HIV research: a preventive treatment.